€172,222
▼ Sales (12 ops.)
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Carter Todd Alfred. Officer active across 1 company, notably Voyager Therapeutics, Inc.. In total, 18 disclosures have been published. Split: 0 buy · 12 sells. Total volume traded: €172k. Activity tracked since 31 December 2022. The latest transaction was filed on 24 February 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Carter Todd Alfred
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
4,174 shares@ US$3.766.6% of flowCommon StockSEC:0001104659-26-020176:0
3,301 shares@ US$3.444.8% of flowCommon StockSEC:0001104659-26-018130:0
3,525 shares@ US$3.855.7% of flowCommon StockSEC:0001104659-26-013408:0
33,000 shares0Common StockSEC:0001104659-26-012677:0
3,305 shares@ US$4.268.1% of flowCommon StockSEC:0001104659-25-016522:0
5,413 shares@ US$4.4514.1% of flowCommon StockSEC:0001104659-25-012200:0
1,191 shares@ US$5.133.6% of flowCommon StockSEC:0001104659-25-003772:0
602 shares@ US$7.682.6% of flowCommon StockSEC:0001104659-24-026554:0
38,500 shares0Common StockSEC:0001104659-24-024993:0
1,266 shares@ US$7.185.0% of flowCommon StockSEC:0001104659-24-005244:0
5,000 shares@ US$2.8512.1% of flowCommon StockSEC:0001104659-23-101631:0
5,500 shares@ US$10.8032.8% of flowCommon StockSEC:0001104659-23-079686:0
5,000 shares@ US$2.857.9% of flowCommon StockSEC:0001104659-23-078152:0
2,193 shares@ US$7.769.6% of flowCommon StockSEC:0001104659-23-035642:0
34,000 shares0Common StockSEC:0001104659-23-024423:0
797 shares@ US$7.673.4% of flowCommon StockSEC:0001104659-23-022430:0
706 shares@ US$9.573.8% of flowCommon StockSEC:0001104659-23-005050:0
388 shares@ US$5.171.1% of flowCommon StockSEC:0001104659-23-002718:0
About Carter Todd Alfred
Carter Todd Alfred is a declarant linked to Voyager Therapeutics, Inc., where he is Chief Scientific Officer. He has 18 filings in total, and within the recent filings covered here, the transactions are entirely sales, for a total of EUR 172222 between 2023-01-10 and 2026-02-26.